Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Julphar
UBS
Deloitte
Teva
Merck

Generated: September 19, 2019

DrugPatentWatch Database Preview

Drug Master Files for: amantadine

  Try a free trial


See Plans and Pricing

« Back to Dashboard


amantadine Drug Master Files

DMF No. Status Type Submission Date Holder Subject
23528 A II 2/11/2010 OLAINFARM JSC AMANTADINE HYDROCHLORIDE
25151 A II 7/21/2011 ZHEJIANG APELOA KANGYU PHARMACEUTICAL CO LTD AMANTADINE HYDROCHLORIDE USP
2817 I II 1/7/1977 CILAG CHEMIE AG AMANTADINE HCL
29486 A II 9/1/2015 ANONIMA MATERIE SINTETICHE AND AFFINI (AMSA) SPA AMANTADINE HYDROCHLORIDE
3739 I II 2/21/1980 CHEMOSWED AB 1-AMINOADAMANTANE HCL (AMANTADINE HCL)
6924 A II 4/8/1987 MOEHS IBERICA SL AMANTADINE HYDROCHLORIDE
9665 I II 4/28/1992 NORTHEAST GENERAL PHARMACEUTICAL FACTORY AMANTADINE HYDROCHLORIDE
>DMF No. >Status >Type >Submission Date >Holder >Subject

Subscribe to access the full database, or try a Free Trial


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Merck
Federal Trade Commission
UBS
Johnson and Johnson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.